Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study

@article{Chen2014IncreasedRO,
  title={Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study},
  author={San-Ni Chen and Ie-Bin Lian},
  journal={British Journal of Ophthalmology},
  year={2014},
  volume={98},
  pages={997 - 997}
}
Aims To investigate whether patients with central serous chorioretinopathy (CSCR) have increased risk of coronary heart disease (CHD). Methods Population-based retrospective cohort and case control study. Longitudinal data from the Taiwan National Health Insurance Research Database (2000 – 2009) were analysed. The study cohort comprised 835 patients with a diagnosis of CSCR and 4175 age and gender matched patients without CSCR. Kaplan – Meier plots and log-rank tests were used to compare… 

INCREASED INCIDENCE OF PEPTIC ULCER DISEASE IN CENTRAL SEROUS CHORIORETINOPATHY PATIENTS: A Population-Based Retrospective Cohort Study

Peptic ulcer disease and higher monthly income are independent risk factors for CSR, whereas, patients with CSR also had increased risk for peptic ulcers development.

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study

In the recent article published in British Journal of Ophthalmology , Chen et al 1 concluded that central serous chorioretinopathy (CSCR) was a risk factor for coronary heart disease (CHD). The

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study

The authors conclude that those with CSCR (specifically males) had a higher rate of developing CHD than those without C SCR.

RISK OF RETINAL VEIN OCCLUSION WITH CENTRAL SEROUS CHORIORETINOPATHY

Central serous chorioretinopathy increases the risk of RVO in CSCR patients, and the authors recommend thorough retinal vessel evaluation, regular follow-up, and education regarding RVO for patients with C SCR.

Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study

It is important to take into account the various risk factors for CSR, so as to define vulnerable groups and to shed light into the pathogenesis of the disease.

Response to comments on: Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy

In CSC patients, monocyte to high‐density lipoprotein (HDL) ratio (MHR) ratio was found to be higher when compared to healthy controls and it was reported that CSC is associated with type A personality which could increase risk for cardiovascular disease even in younger ages.

RISK OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CENTRAL SEROUS CHORIORETINOPATHY

It was found that CSCR increased the risk of RRD even after adjustment for age, sex, and comorbidities including status after cataract operation, blunt trauma, myopia, diabetes mellitus, hypertension, and hyperlipidemia.

Peripheral Vascular Endothelial Dysfunction in Central Serous Chorioretinopathy.

Purpose To explore the pathophysiology of central serous chorioretinopathy (CSC) by comparing peripheral vascular endothelium function in patients with CSC and control subjects. Methods This study

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

Cerebral Neurovascular Coupling Impairment in Central Serous Chorioretinopathy

CSCR patients presented a significantly impaired cerebral NVC compared to controls, supporting the theory of a potential systemic vascular dysfunction and stress could be related to this NVC impairment.

References

SHOWING 1-10 OF 29 REFERENCES

Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study

CSCR is an independent indicator for the increased risk of subsequent ischaemic stroke development and is found to have a 1.56-fold (95% CI 1.11 to 2.18, p=0.010) greater risk of a subsequent ishaemic stroke than the matched controls.

FXIII-A Leu34 genetic variant in premature coronary artery disease: A genotype – phenotype case control study

FXIII-A Leu34 is a polymorphism which provides a strong resistance to fibrinolysis with a gene-dose effect, but does not relate to premature CAD or to recurrent coronary events in this study.

Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease

The male relatives of patients with premature CAD form fibrin clots that begin polymerization more quickly, have thicker fibers, and are less permeable than those of control subjects.

Systemic findings associated with central serous chorioretinopathy.

Central serous chorioretinopathy: a pathogenetic model

The formulation of a causative model of CSCR enables to understand how the therapeutic approach cannot be based on a generalized therapy but should be individualized for each patient, and that sometimes a combined strategy of treatment is required.

[Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy].

The levels of t-PA activity, t- PA antigen and plasminogen activator inhibitor-1 (PAI-1) in blood from the patients with central serous chorioretinopathy were compared with the levels of total cholesterols, triglycerides, and high-density lipoprotein cholesterol (HDL).